Notes: February 3, 2026 -- Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to “Chiron Real Estate Inc.” Beginning on February 23, 2026, the Company’s common stock will trade on the New York Stock Exchange (the “NYSE”) under the new name, “Chiron Real Estate Inc.,” and ticker symbol “XRN.”
“After spending the last six months evaluating and redefining our strategy, we are rebranding to better align with our new mission,” Mark Decker, Jr., Chief Executive Officer, said. “Chiron (Kai-ron), a figure from Greek mythology known for his knowledge and skill with medicine, was highly revered as a teacher and tutor and we believe Chiron embodies our refreshed mission: to deliver value at the intersection of care, capital and real estate, and our values of integrity and thought leadership.”
The Company expects to publish an investor presentation outlining the Company’s 2026 strategic objectives alongside its fourth quarter earnings release.
In connection with the name change, effective on February 23, 2026, the Company’s trading symbols on the NYSE will change from “GMRE” to “XRN” for the Company’s common stock, from “GMRE PrA” to “XRN PrA” for the Company’s Series A Preferred Stock, par value $0.001 per share, and from “GMRE PrB” to “XRN PrB” for the Company’s Series B Preferred Stock, par value $0.001 per share.
The Company’s rebrand will affect the Company’s business operations through its passion to deliver value for all its stakeholders, but it will not affect some of the Company’s core components such as its organizational structure, stockholder rights or qualification as a REIT for U.S. federal income tax purposes. The Company’s outstanding securities will remain valid, and no action is required by securityholders because of the name or ticker changes. There will be no change to the Company’s CUSIP numbers in connection with the name and ticker symbol changes.
September 18, 2025 -- Global Medical REIT Inc. (the “Company”), the Company filed Articles of Amendment to its charter (the “Amendment”) with the Maryland State Department of Assessments and Taxation. The Amendment, effective as of 5:00 p.m. Eastern Time on September 19, 2025 (the “Effective Time”), converted every five shares of the issued and outstanding Common Stock into one share of common stock of the Company, par value $0.005 per share. The Reverse Stock Split also effected a proportionate reduction in the Company’s authorized shares of Common Stock from 500,000,000 shares to 100,000,000. The Common Stock will begin trading on a reverse split-adjusted basis on the New York Stock Exchange (the “NYSE”) at the opening of trading on September 22, 2025. The Common Stock will continue trading on the NYSE under the symbol “GMRE” with a new CUSIP number (37954A303).
